<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Cantor Fitzgerald issued an analysis on Aleafia Health Inc. (TSX:AH) (OTCQX:ALEAF), after the company released its financial results earlier Thursday for the second quarter of this year, which revealed a 53% sequential increase in cannabis net revenue, totaling roughly $9.6 million in the second quarter of 2021. Cantor remained Neutral but lowered its 12-month price target to C$0.42 from C$0.50 due to the sectoral derating.
...read full article on Benzinga
